Clinical Updates In Advanced Bladder Cancer

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Clinical Updates In Advanced Bladder Cancer

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

ASCO 2022 Defining "Platinum-Ineligible" Pts With Metastatic Urothelial Cancer

By ASCO 2022 Conference Coverage FEATURING Shilpa Gupta

262 views

June 14, 2022

Comments 0

ASCO GU 2022 on EV-103 Cohort H: Antitumor Activity of Neoadjuvant T…

ASCO Genitourinary Cancers Symposium

N. Mar

185 views

ESMO 2022 on the Impact of TURBT and Intravesical BCG vs. Radical Cy…

ESMO 2022 Conference Coverage

P. Haddad

136 views

ESMO 2022 on the 4-Factor Model to Predict Response and Survival Ben…

ESMO 2022 Conference Coverage

G. Sonpavde

134 views

2022 ASCO Updates in Bladder and Prostate Cancers

Total Health

M. Bupathi

145 views

ASCO GU 2022 on Multi-Institutional Matched Comparison of Radical Cy…

ASCO Genitourinary Cancers Symposium

A. Zlotta

132 views

Trials in Progress in Neoadjuvant Systemic Therapy in MIBC

ASCO Genitourinary Cancers Symposium

P. Grivas

197 views

ASCO GU 2022 on a Study EV-103 Cohort H: Antitumor Activity of Neoad…

ASCO Genitourinary Cancers Symposium

D. Petrylak

160 views

ASCO GU 2022 Highlights on the ADCs in Advanced Urothelial Cancer: C…

ASCO Genitourinary Cancers Symposium

S. Tagawa

165 views

Perioperative Systemic Therapies in MIBC

PROSCA & BLADDR 2021

F. Witjes

85 views

Are We Ready for ctDNA Triggered Therapy for Bladder Cancer?

PROSCA & BLADDR 2021

B. Szabados

150 views

PD-L1 in Metastatic Bladder Cancer

GRACE

J. Brown

242 views

ASCO 2022: A Phase II Study of Gem + Cis Chemo in MIBC With Bladder …

ASCO 2022 Conference Coverage

G. Iyer

131 views

ASCO 2022 Real-World Treatment Patterns and Clinical Outcomes With 1…

ASCO 2022 Conference Coverage

G. Sonpavde

185 views

ASCO 2022 Highlights From Educational Sessions and Updates in Bladde…

ASCO 2022 Conference Coverage

P. Grivas

728 views

ASCO 2022 MAIN-CAV: Phase III Randomized Trial of Maintenance Caboza…

ASCO 2022 Conference Coverage

S. Gupta

722 views

ASCO 2022 Panel Discussion on Current Strategies and Trials on Bladd…

ecancer

P. Grivas, R. Jones, P. Cornford, K. Miller

139 views

ASCO 2022 Bladder Cancer Highlights

ASCO 2022 Conference Coverage

G. Sonpavde

810 views

Penn Medicine Updates on RCC & Bladder Cancer Treatment

Penn Medicine Abramson Cancer Center

V. Narayan

150 views

ESMO 2022: Key Bladder Cancer/Urothelial Carcinoma Presentations

ESMO 2022 Conference Coverage

G. Sonpavde

810 views

ESMO 2022 on the Results From the PREVAIL Prospective Cohort Study: …

ESMO 2022 Conference Coverage

P. Grivas

149 views

Multiple Cases Discussion: Oligometastatic Bladder Cancer

PROSCA & BLADDR 2022

V. Fonteyne, K. Gust, U. Vogl, P. Grivas

121 views

DEBATE: Are We Evolving Towards a Platinum-Free Future in Bladder Ca…

PROSCA & BLADDR 2022

A. Bamias

92 views

The Growing Landscape of Antibody-Drug Conjugates in Advanced UC

PROSCA & BLADDR 2022

P. Grivas

127 views